NEWS & EVENTS 
SPECIALTY CARE
Type 2 diabetes is one of the most common, costly, and disabling diseases in the world. Approximately one million patients in Michigan have type 2 diabetes and rates are up to 2x higher for Michiganders who are Black, Latino, or have a disability. At the same time, the implementation of guideline concordant diabetes care lags behind due to challenges with coverage, lack of resources, cost of medications, and lack of support and education. Primary care practices continue to combat staffing issues, lack of resources, and increasing administrative demands. Meanwhile coordination of care for diabetes is confounded by an increasingly-complex healthcare system.
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work.
Mission
MCT2D strives to prevent type 2 diabetes and its complications by fostering a collaborative community of clinicians and patients to accelerate the equitable implementation of evidence-based diabetes care for all patients in Michigan.
Vision
A world where Type 2 Diabetes is no longer a progressive disease.
Care for all Vision
We envision a Michigan where all individuals have equitable access to the best care for type 2 diabetes regardless of race, ethnicity, socio-economic status, insurance coverage, or geographic location. Our collaborative efforts will lead to reduced prevalence and complications of type 2 diabetes and improved quality of life for every patient.
LEARN MORE Quality Initiatives
Together, we work to accelerate the implementation of quality diabetes care, including three guiding initiatives
MORE ON QUALITY INITIATIVES
Care Collaboration
Bringing together primary care, endocrinology, nephrology, obesity medicine, pharmacy, dietetics, care management, and more to advance as a team.
Our Members
The Michigan Collaborative for Type 2 Diabetes is a coalition of over 1000 physicians, coming together from across 346 primary care, endocrinology, and nephrology practices, all of whom are represented by 28 physician organizations spanning the state.
MORE ON MEMBERSHIPHow MCT2D Supports Members
Nearly 100 free tools and resources, developed and curated by the MCT2D team.
Guides to coverage for CGM, GLP-1 RA and SGLT2i, patient education on low carb lifestyle, videos, interactive websites, one-page handouts, and more.
Know exactly what you need to do next using our administrative portal.
Monitor your practices’ and physicians’ participation in real-time and never miss a VBR deadline with auto-reminders and customized check lists. Requires Member Login - Ask PO Lead for Access
Get support, learn, and grow in community.
Monthly learning events with continuing education and VBR credit. Workgroups and networking for the entire diabetes care team. Crowdsourced knowledge like our dot phrase library and best practice database. One-on-one consultations with MCT2D experts.
A responsive team, ready to answer your questions.
Connect with the MCT2D coordinating center by email: ccteam@mct2d.org or learn more about us.
Meet the Program Directors
Lauren Oshman, MD, MPH
Program Director
Dr. Oshman is a family physician and clinical associate professor in the University of Michigan Department of Family Medicine. Prior to joining the University of Michigan in 2020, she practiced for five years in Concord, New Hampshire, then served as a residency faculty member and vice-chair for quality at NorthShore University Health System in Chicago.
-style {font-size: 20px; color: #E7A02F; font-weight: bold;}-Heidi L. Diez, PharmD, BCACP, BC-ADM-end style-
Co-Director
Dr. Diez is a clinical pharmacist specialist and clinical associate professor in the University of Michigan College of Pharmacy. She graduated from the University of Michigan (UM) College of Pharmacy (2004) and completed a community practice residency at the University of Washington and Kelley Ross Pharmacy in Seattle, WA (2005).
OUR TEAM
NEWSLETTERS
News from the MCT2D Team
Coverage Changes in 2026...PLUS the 2026 PDF Coverage Guide
Last updated: Wednesday, December 24, 2025
At our Fall 2025 virtual regional meetings, co-program director Heidi Diez, PharmD highlighted some of coverage changes coming 2026.
Ending: MCT2D Gold Carding Program for CGM
Plan(s) Impacted: BCBSM Commercial members
Products Impacted: CGM for type 2 diabetes
Effective: January 1, 2026
HCPs impacted: MCT2D and PDCM-participating physicians and advanced practice providers (APPs)
See BCBSM September 25, 2025 Provider Alert: https://michmed.org/kV5DK
MCT2D and PDCM-participating prescribers will no longer be able to “by-pass” prior authorization for CGM prescriptions prescribed after January 1, 2026.
This time-saving “gold carding” program was first initiated through an MCT2D and BCBSM partnership in 2024, granting participating MCT2D and Blue Cross PDCM physicians the ability to prescribe CGMs for patients with type 2 diabetes without the need for prior authorization.
MCT2D-participating physicians and advanced practice providers should be advised of this change. Active and approved “gold-carded” PAs approved prior to January 1, 2026 will be recognized until the end of the 12-month PA term (up to 12/31/2026).
Download the 2026 MCT2D Medication and CGM Coverage Guide
Click image to download
NovoCare Discontinues Assistance Program for Medicare Patients in Need. What do next in 2025-2026?
Last updated: Monday, November 3, 2025
As Medicare Advantage and Part D open enrollment for 2026 begins, many patients with type 2 diabetes are facing new uncertainty about how to afford their medications—especially those who rely on the NovoCare Patient Assistance Program for Ozempic.
Clinicians Learn by Doing in MCT2D’s Weeklong Low-Carb Counseling Training Program
Last updated: Tuesday, October 28, 2025
The weeklong low carb diet training program—titled Elevate Your Care: Low Carb Counseling for Healthcare Professionals—held its first five-day virtual course in May 2025, with a cohort of 13 physicians, pharmacists, nurses, and dietitians from across the collaborative. The training program was developed by a team of MCT2D experts, with leadership from Rina Hisamatsu, RDN, MPH, lead dietitian.
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.